239 related articles for article (PubMed ID: 16480743)
1. Serum anti-Glc(alpha1,4)Glc(alpha) antibodies as a biomarker for relapsing-remitting multiple sclerosis.
Schwarz M; Spector L; Gortler M; Weisshaus O; Glass-Marmor L; Karni A; Dotan N; Miller A
J Neurol Sci; 2006 May; 244(1-2):59-68. PubMed ID: 16480743
[TBL] [Abstract][Full Text] [Related]
2. Serum anti-GAGA4 IgM antibodies differentiate relapsing remitting and secondary progressive multiple sclerosis from primary progressive multiple sclerosis and other neurological diseases.
Brettschneider J; Jaskowski TD; Tumani H; Abdul S; Husebye D; Seraj H; Hill HR; Fire E; Spector L; Yarden J; Dotan N; Rose JW
J Neuroimmunol; 2009 Dec; 217(1-2):95-101. PubMed ID: 19879655
[TBL] [Abstract][Full Text] [Related]
3. Anti-alpha-glucose-based glycan IgM antibodies predict relapse activity in multiple sclerosis after the first neurological event.
Freedman MS; Laks J; Dotan N; Altstock RT; Dukler A; Sindic CJ
Mult Scler; 2009 Apr; 15(4):422-30. PubMed ID: 19324980
[TBL] [Abstract][Full Text] [Related]
4. Serum IgG and IgM ganglioside GM1 antibodies in patients with multiple sclerosis.
Zaprianova E; Majtényi K; Deleva D; Mikova O; Filchev A; Sultanov B; Kolyovska V; Sultanov E; Christova L; Kmetska X; Georgiev D
Ideggyogy Sz; 2004 Mar; 57(3-4):94-9. PubMed ID: 15133910
[TBL] [Abstract][Full Text] [Related]
5. Serum autoantibodies to cell surface determinants in multiple sclerosis: a flow cytometric study.
Lily O; Palace J; Vincent A
Brain; 2004 Feb; 127(Pt 2):269-79. PubMed ID: 14662514
[TBL] [Abstract][Full Text] [Related]
6. Evolution of self-reactive IgG antibody repertoires in patients with relapsing-remitting multiple sclerosis.
Lionel A; de Seze J; Didier L; Sandrine FN; Sylvain D; Patrick V; Lionel P
Immunol Lett; 2005 Feb; 97(1):55-62. PubMed ID: 15626476
[TBL] [Abstract][Full Text] [Related]
7. Neurofilament light antibodies in serum reflect response to natalizumab treatment in multiple sclerosis.
Amor S; van der Star BJ; Bosca I; Raffel J; Gnanapavan S; Watchorn J; Kuhle J; Giovannoni G; Baker D; Malaspina A; Puentes F
Mult Scler; 2014 Sep; 20(10):1355-62. PubMed ID: 24515731
[TBL] [Abstract][Full Text] [Related]
8. An N-glucosylated peptide detecting disease-specific autoantibodies, biomarkers of multiple sclerosis.
Lolli F; Mulinacci B; Carotenuto A; Bonetti B; Sabatino G; Mazzanti B; D'Ursi AM; Novellino E; Pazzagli M; Lovato L; Alcaro MC; Peroni E; Pozo-Carrero MC; Nuti F; Battistini L; Borsellino G; Chelli M; Rovero P; Papini AM
Proc Natl Acad Sci U S A; 2005 Jul; 102(29):10273-8. PubMed ID: 16014416
[TBL] [Abstract][Full Text] [Related]
9. Increased prevalence of and gene transcription by Chlamydia pneumoniae in cerebrospinal fluid of patients with relapsing-remitting multiple sclerosis.
Dong-Si T; Weber J; Liu YB; Buhmann C; Bauer H; Bendl C; Schnitzler P; Grond-Ginsbach C; Grau AJ
J Neurol; 2004 May; 251(5):542-7. PubMed ID: 15164186
[TBL] [Abstract][Full Text] [Related]
10. Anti-myelin antibodies predict the clinical outcome after a first episode suggestive of MS.
Tomassini V; De Giglio L; Reindl M; Russo P; Pestalozza I; Pantano P; Berger T; Pozzilli C
Mult Scler; 2007 Nov; 13(9):1086-94. PubMed ID: 17468447
[TBL] [Abstract][Full Text] [Related]
11. Anti-GM1 antibodies are not associated with cerebral atrophy in patients with multiple sclerosis.
Valentino P; Labate A; Nisticò R; Pirritano D; Cerasa A; Liguori M; Bastone L; Crescibene L; Quattrone A
Mult Scler; 2009 Jan; 15(1):114-5. PubMed ID: 18845652
[TBL] [Abstract][Full Text] [Related]
12. Increased cerebrospinal fluid chitotriosidase index in patients with multiple sclerosis.
Verbeek MM; Notting EA; Faas B; Claessens-Linskens R; Jongen PJ
Acta Neurol Scand; 2010 May; 121(5):309-14. PubMed ID: 19925532
[TBL] [Abstract][Full Text] [Related]
13. The glycopeptide CSF114(Glc) detects serum antibodies in multiple sclerosis.
Lolli F; Mazzanti B; Pazzagli M; Peroni E; Alcaro MC; Sabatino G; Lanzillo R; Brescia Morra V; Santoro L; Gasperini C; Galgani S; D'Elios MM; Zipoli V; Sotgiu S; Pugliatti M; Rovero P; Chelli M; Papini AM
J Neuroimmunol; 2005 Oct; 167(1-2):131-7. PubMed ID: 16051375
[TBL] [Abstract][Full Text] [Related]
14. Potential relevance of cerebrospinal fluid and serum levels and intrathecal synthesis of active matrix metalloproteinase-2 (MMP-2) as markers of disease remission in patients with multiple sclerosis.
Fainardi E; Castellazzi M; Tamborino C; Trentini A; Manfrinato MC; Baldi E; Tola MR; Dallocchio F; Granieri E; Bellini T
Mult Scler; 2009 May; 15(5):547-54. PubMed ID: 19318509
[TBL] [Abstract][Full Text] [Related]
15. IgM to S-nitrosylated protein is found intrathecally in relapsing-remitting multiple sclerosis.
Hvaring C; Vujicic S; Aasly JO; Feinstein DL; White LR; Boullerne AI
J Neuroimmunol; 2013 Mar; 256(1-2):77-83. PubMed ID: 23351705
[TBL] [Abstract][Full Text] [Related]
16. Endothelin and nitric oxide levels in cerebrospinal fluid of patients with multiple sclerosis.
Speciale L; Sarasella M; Ruzzante S; Caputo D; Mancuso R; Calvo MG; Guerini FR; Ferrante P
J Neurovirol; 2000 May; 6 Suppl 2():S62-6. PubMed ID: 10871788
[TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinase-9 and matrix metalloproteinase-2 as biomarkers of various courses in multiple sclerosis.
Benesová Y; Vasku A; Novotná H; Litzman J; Stourac P; Beránek M; Kadanka Z; Bednarík J
Mult Scler; 2009 Mar; 15(3):316-22. PubMed ID: 19153173
[TBL] [Abstract][Full Text] [Related]
18. Absence of neuromyelitis optica IgG antibody in an active relapsing-remitting multiple sclerosis population.
Smith CH; Waubant E; Langer-Gould A
J Neuroophthalmol; 2009 Jun; 29(2):104-6. PubMed ID: 19491632
[TBL] [Abstract][Full Text] [Related]
19. Increased serum levels of soluble CD14 indicate stable multiple sclerosis.
Lutterotti A; Kuenz B; Gredler V; Khalil M; Ehling R; Gneiss C; Egg R; Deisenhammer F; Berger T; Reindl M
J Neuroimmunol; 2006 Dec; 181(1-2):145-9. PubMed ID: 17046070
[TBL] [Abstract][Full Text] [Related]
20. Antibody responses against galactocerebroside are potential stage-specific biomarkers in multiple sclerosis.
Menge T; Lalive PH; von Büdingen HC; Cree B; Hauser SL; Genain CP
J Allergy Clin Immunol; 2005 Aug; 116(2):453-9. PubMed ID: 16083805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
